The researchers describe how the two pathways interact to produce their combined effect in a study in the journal Genes and Development that is available online.
Tumor growth occurs upon disruption of the regulation of the cell cycle, the cascade of events that result in the division and duplication of a cell. One critical pathway regulating the cell cycle is the retinoblastoma (Rb) tumor suppressor pathway. The Rb pathway is found to be mutated or functionally inactivated in nearly all human cancers.
Maxim Frolov, UIC associate professor of biochemistry and molecular genetics, models development of human cancer by studying inactivation of Rb in fruit flies. In flies, a deficiency in the Rb pathway alone, he says, surprisingly causes only subtle defects in cell proliferation, but does not result in a full-blown tumor.
"We wanted to understand why,” he said.
One possible explanation was that other regulatory pathways were working together with the Rb pathway. In their previous studies, the researchers had found a pathway called Hippo, which seemed to work with Rb in regulation of cell proliferation.
In the new study, Frolov and his colleagues showed that simultaneously inactivating both pathways led to a marked enhancement of tumor growth. The researchers were able to trace the mechanism responsible for the synergy between these two pathways. They found that inactivation of the Hippo and Rb pathways results in an up-regulaton of a unique set of genes.
“We saw that the genes important to cell proliferation and cell cycle regulation are inappropriately expressed in these cells,” Frolov said. The genes were not up-regulated when either the Rb or Hippo pathway alone was inactivated.
“We found that transcription factors -- proteins that turn genes on and off -- involved in each of the two pathways cooperate in inducing expression of these cell-cycle specific genes, resulting in inappropriate cell proliferation,” he said.
The way Hippo is able to cross-talk with the Rb pathway and disrupt cell-cycle regulation to grow tumors may have important implications for understanding the complexity of mutations in human cancers, Frolov said. The finding suggests that there may be other factors that work with Rb to promote tumor growth.
"We should be looking for more cooperating mutations in human cancers,” he said.
The work is the result of international collaboration between Frolov’s laboratory at UIC and Nuria Lopez-Bigas’s genomics group at the University of Pompeu Fabra in Barcelona, Spain. Brandon Nicolay and Battuya Bayarmagnai of UIC's department of biochemistry and molecular genetics and Abul B.M.M.K. Islam of the University Pampeu Fabra contributed to the study. Funding was provided by grants from the National Institutes of Health and the Spanish Ministerio de Educacion y Ciencia and Agència de Gestió d'Ajuts Universitaris i de Recerca of the Catalonian government and from a scholar award from the Leukemia and Lymphoma Society and a NIH National Research Service Award.
For more information about UIC, visit www.uic.edu
NOTE: Please refer to the institution as the University of Illinois at Chicago on first reference and UIC on second reference. "University of Illinois" and "U. of I." are often assumed to refer to our sister campus in Urbana-Champaign.
Jeanne Galatzer-Levy | Newswise Science News
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences